Ozempic 2 mg solution for injection in pre-filled pen
*Company:
Novo Nordisk LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 17 June 2026
File name
Ozempic SmPC_IE_v24_Jun2026_cl.pdf
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 2 - Qualitative and quantitative composition
- Change to section 6.1 - List of excipients
- Change to section 6.3 - Shelf life
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Section 1: Addition of pre-filled syringe presentations
Section 2: Addition of pre-filled syringe details
Section 6.1: Addition of pre-filled syringe details
Section 6.3: Addition of pre-filled syringe shelf life
Section 6.4: Addition of pre-filled syringe storage
Section 6.5: Addition of pre-filled syringe container & pack size
Section 6.6: Addition of pre-filled syringe details
Section 8: Addition of pre-filled syringe MA numbers
Section 10: Date of revision of the text
Updated on 06 May 2026
File name
Ozempic 2mg leaflet_01-2026_v3_cl.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 06 May 2026
File name
Ozempic SmPC_IE_v23_Mar2026_cl.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 February 2026
File name
Ozempic SmPC_IE_v22_Nov2025_cl.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 February 2026
File name
Ozempic 2mg leaflet_01-2026_v1_clean.pdf
Reasons for updating
- New PIL for new product
Novo Nordisk Limited
Address:
1st Floor, Block A, The Crescent Building, Northwood Business Park, Santry, Dublin 9, IrelandMedical Information E-mail:
infoireland@novonordisk.comTelephone:
+353 1 8629700 ,Fax:
+353 1 8629725Website:
https://www.novonordisk.ie